Lakes Region Mental Health Center and Netsmart Collaborate to Deliver Integrated Care

OVERLAND PARK, Kan.–(BUSINESS WIRE)–#ArtificialIntelligence—Lakes Region Mental Health Center (LRMHC) and Netsmart announce they are expanding their 33-year partnership through the adoption of the CareFabric® platform to enhance clinical, financial and operational processes across the organization’s behavioral health services and treatment programs. By adopting the CareFabric platform, LRMHC will benefit from a solution focused on clinical … [Read more…]

Propanc Biopharma Confirms PRP Exerts Significant Effects Against Chemoresistant Pancreatic Tumor Cells

MELBOURNE, Australia–(BUSINESS WIRE)–Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, today announced that PRP exerts significant effects against chemoresistant pancreatic tumor cells, as reported by one of the Company’s joint researchers, Mrs. Belén Toledo Cutillas MSc, at the … [Read more…]

Zebra’s New Environmental Sensors Increase Supply Chain Visibility in Food, Pharmaceutical and Healthcare Industries

Manufacturing, transportation and logistics operators can maximize productivity with more efficient data logger and improve profitability through immediate corrective actions. LINCOLNSHIRE, Ill.–(BUSINESS WIRE)–Zebra Technologies Corporation (NASDAQ: ZBRA), an innovator at the front line of business with solutions and partners that deliver a performance edge, today announced it will showcase its new line of environmental sensors … [Read more…]

Stevanato Group Collaborates with Recipharm to Develop and Manufacture Pre-fillable Syringes for Use in a New Soft Mist Inhaler for the Inhalation of Sensitive Biological Products

The new strategic collaboration aims to provide innovative primary packaging to pharmaceutical and biopharmaceutical companies using Recipharm’s proprietary soft mist inhalers. PIOMBINO DESE, Italy–(BUSINESS WIRE)–Stevanato Group S.p.A. (NYSE: STVN) a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today announced a collaboration with leading … [Read more…]

Vertex Announces Publication in New England Journal of Medicine of Results from Phase 2 Study of Inaxaplin (VX-147)

BOSTON–(BUSINESS WIRE)–Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced publication in the New England Journal of Medicine (NEJM) of results from preclinical studies and a Phase 2 study evaluating the efficacy and safety of inaxaplin (VX-147) on top of standard-of-care in people with focal segmental glomerulosclerosis (FSGS) and two APOL1 variants, a severe, rapidly progressive form … [Read more…]

Jnana Therapeutics to Present Preclinical Data on its PKU Program at the 2023 Society for Inherited Metabolic Disorders Annual Meeting

Phase 1a clinical trial of JNT-517 in healthy volunteers approaching completion BOSTON–(BUSINESS WIRE)–Jnana Therapeutics, a clinical-stage biotechnology company leveraging its next-generation chemoproteomics platform to discover medicines for challenging-to-drug targets, will present preclinical data for its lead program, a potential first-in-class, oral small molecule approach for the treatment of phenylketonuria (PKU). Data will be presented in … [Read more…]

iECURE Appoints Gabriel M. Cohn, M.D., as Chief Medical Officer

Dr. Cohn joins iECURE with a combined 30 years of academic medicine and industry expertise in rare genetic disorders with a focus on investigational biologics PHILADELPHIA–(BUSINESS WIRE)–iECURE, a gene editing company focused on mutation-agnostic in vivo gene insertion, or knock-in, editing for the treatment of liver disorders with significant unmet need, today announced the appointment … [Read more…]

Aldeyra Therapeutics Announces Completion of Enrollment in Phase 2 Clinical Trial of ADX‑2191 in Retinitis Pigmentosa

Top-Line Results Expected in the First Half of 2023 LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced the completion of enrollment in the Phase 2 clinical trial of ADX‑2191 (methotrexate injection, USP), an investigational drug candidate, for the treatment of retinitis pigmentosa, a group of rare genetic eye diseases characterized by retinal cell … [Read more…]

LENSAR Reports Fourth Quarter and Full Year 2022 Results and Provides Business Update

Installed ten ALLY® Adaptive Cataract Treatment Systems in 2022 with contracts for six additional ALLY Systems executed in December 2022; Installations expected in first half 2023 Positive surgeon feedback reinforces next generation speed, efficiency and economic benefits of ALLY ORLANDO, Fla.–(BUSINESS WIRE)–LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused … [Read more…]

Applied UV to Host Fourth Quarter and Year End 2022 Conference Call on April 3, 2023

MOUNT VERNON, N.Y.–(BUSINESS WIRE)–Applied UV, Inc. (NasdaqCM: AUVI) (“Applied UV” or the “Company”), a global leading provider of patented, scientifically proven surface and air disinfection technologies encompassing fixed, mobile, and HVAC, with best-in-class LED lighting products and premium hotel furnishings, announced that the Company will be hosting an investor conference call and live webcast on … [Read more…]